Back
Allogene Therapeutics Vs. Envista Holdings Industry Stock Comparison
Buy
59
ALLO
Allogene Therapeutics
Last Price:
3.25
Seasonality Move:
-10.11%
Sell
48
NVST
Envista Holdings
Last Price:
21.62
Seasonality Move:
15.28%
Buy
59
Allogene Therapeutics (ALLO)
is a Buy
Is Allogene Therapeutics a Buy, Sell or Hold?
- The current Allogene Therapeutics [ALLO] share price is $2.99. The Score for ALLO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- ALLO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Envista Holdings (NVST)
is a Sell
Is Envista Holdings a Buy, Sell or Hold?
- The current Envista Holdings [NVST] share price is $21.10. The Score for NVST is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- NVST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALLO Stock Price Chart
What is Allogene Therapeutics's stock price today?
-
The Allogene Therapeutics share price today is $2.99
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALLO is experiencing slight buying pressure.
NVST Stock Price Chart
What is Envista Holdings's stock price today?
-
The Envista Holdings share price today is $21.10
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVST is experiencing slight buying pressure.
ALLO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 58.5 | Buy |
| Chaikin Money Flow: | 974664 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.57 - 2.83) | Buy |
| Bollinger Bands (100): | (2.39 - 2.91) | Buy |
NVST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.62 | Buy |
| Relative Strength Index (14 RSI): | 69.41 | Buy |
| Chaikin Money Flow: | 761231 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.99 - 20.01) | Buy |
| Bollinger Bands (100): | (16.45 - 19.07) | Buy |
ALLO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.73 | Buy |
| 20-day SMA: | 2.72 | Buy |
| 50-day SMA: | 2.71 | Buy |
| 200-day SMA: | 3.18 | Sell |
| 8-day EMA: | 2.8 | Buy |
| 20-day EMA: | 2.74 | Buy |
| 50-day EMA: | 2.71 | Buy |
| 200-day EMA: | 3.09 | Sell |
NVST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.05 | Buy |
| 20-day SMA: | 19.04 | Buy |
| 50-day SMA: | 18.76 | Buy |
| 200-day SMA: | 19.25 | Buy |
| 8-day EMA: | 20.3 | Buy |
| 20-day EMA: | 19.5 | Buy |
| 50-day EMA: | 18.82 | Buy |
| 200-day EMA: | 20.02 | Buy |
Allogene Therapeutics Earnings Growth & ALLO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and a decrease next year of $0.15 per share.
Envista Holdings Earnings Growth & NVST Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.87 per share, and an increase next year of $0.42 per share.
Allogene Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Envista Holdings Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||